Debra Matthews @bermaninstitute - we don’t have good models for scientists to have public conversations about how science (like #CRISPR) ought to be used. Check out @nisenet #buildingwithbiology resources! #GeneEditing360 #scicomm #sciengage http://buildingwithbiology.org
Insurance expert Ed Pezalla - coverage of #CRISPR treatments, like other healthcare, would be influenced by constraints on resources & distribution of benefits; tension between priorities of public vs private insurance. #GeneEditing360
Debra Matthews from @bermaninstitute - ethical questions of human germline editing w #CRISPR: safety, consent, justice, commodification, treatment vs enhancement. Every country needs broad public conversations. #GeneEditing360
Bob Oakes discusses #CRISPR IP disputes and legal implications - currently free to academic/nonprofit research, but licenses for commercial use are exclusive. Does this overly limit innovation? #GeneEditing360
Eric Kmiec from @GeneEditingDE highlights impt (& feasible) clinical applications of #CRISPR: delete lung cancer gene to improve response to chemotherapy, delete viruses from pigs to reduce rejection of organ transplants in humans. #GeneEditing360
